Skip to main navigation
Allogene Therapeutics
Contact Us
Careers
SHARE
Email Us
Print
Allogene Therapeutics
  • About Us
    • At A Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Our Culture
  • AlloCAR T™
    • History of CAR T
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • ALLOGENEIC CELL THERAPY STRATEGY
    • On-demand Availability
  • Pipeline
    • Clinical Trials
    • Expanded Access
    • Scientific Publications
  • Our Culture
    • ESG Report
    • We are one Allogene
    • REVOLUTIONIZING CELL THERAPY
    • DIVERSITY, EQUITY AND INCLUSION
    • JOIN THE ALLOGENE COMMUNITY
  • News Center
    • Events
    • Press Releases
    • Perspectives
    • Our Tweets
    • Media Resources
    • Community Guidelines
  • INVESTORS
    • IR Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents & Charters
      • ESG Report
      • Board of Directors
      • Management
      • Committee Composition
    • SEC Filings
    • Resources
      • Investor FAQs
      • Email Alerts
      • IR Inquiry

Event Details

Oppenheimer's 32nd Annual Healthcare Conference

Mar 15, 2022 at 10:40 AM EDT

Click here for webcast
Print Page
Email Alerts
RSS Feeds
Investor Contacts
Facebook
Twitter
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene Therapeutics
CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

View Map / Contact Us

  • About Us
  • At a Glance
  • Management Team
  • Board of Directors
  • Scientific Advisors
  • Partners
  • Our Culture
  • ALLOCAR T™
  • History of CAR T
  • Next Revolution in Cell Therapy
  • Platform for Tomorrow
  • Allogeneic Cell Therapy Strategy
  • On-Demand Availability
  • Pipeline
  • Clinical Trials
  • Expanded Access
  • Scientific Publications
  • News Center
  • Events
  • Press Releases
  • Perspectives
  • Our Tweets
  • Media Resources
  • Community Guidelines
  • Investors
  • IR Overview
  • News and Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
  • Corporate Governance
    • Documents & Charters
    • ESG Report
    • Board of Directors
    • Management
    • Committee Composition
  • SEC Filings
  • Resources
  • Investor FAQS
  • Email Alerts
  • IR Inquiry
©2022 Allogene Therapeutics
TERMS OF USE
PRIVACY POLICY
PREFERENCE CENTER